Medicina interna
Servizo
Universidad Autónoma de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (48)
2024
-
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors
Journal of Hepatology, Vol. 80, Núm. 6, pp. 904-912
2023
-
Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value
Respiratory Research, Vol. 24, Núm. 1
-
Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
Annals of the Rheumatic Diseases, Vol. 82, Núm. 12, pp. 1594-1605
2022
-
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019
Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050
-
Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry
International Journal of Infectious Diseases, Vol. 116, pp. 51-58
-
Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial
BMC Cardiovascular Disorders, Vol. 22, Núm. 1
2021
-
Alterations in respiratory function test three months after hospitalisation for covid-19 pneumonia: Value of determining nitric oxide diffusion
Journal of Clinical Medicine, Vol. 10, Núm. 10
-
Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors
HIV Medicine, Vol. 22, Núm. 1, pp. 47-53
-
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884
-
Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients
Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155
-
Reasons for choice of antiretroviral regimens in HIV patients presenting late for initial treatment in Europe
AIDS Patient Care and STDs, Vol. 35, Núm. 4, pp. 110-115
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
2019
-
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice-Vie-KinD study
PLoS ONE, Vol. 14, Núm. 9
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
2018
-
Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis
Gastroenterology, Vol. 155, Núm. 4, pp. 1120-1127.e4
2017
-
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia
Journal of Clinical Lipidology, Vol. 11, Núm. 1, pp. 260-271
-
Predicting cardiovascular events in familial hypercholesterolemia: The SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)
Circulation, Vol. 135, Núm. 22, pp. 2133-2144
-
Réplica a «Tratamiento de la hiperuricemia asintomática»
Revista Clinica Espanola
2016
-
Altered underlying renal tubular function in patients with chronic hepatitis B receiving nucleos(t)ide analogs in a real-world setting the MENTE study
Journal of Clinical Gastroenterology, Vol. 50, Núm. 9, pp. 779-789